Completed PHASE4 INTERVENTIONAL 2-arm NCT00154115

Levosimendan in High Risk Heart Valve Surgery

Efficacy of Levosimendan in Cardiac Failure After Heart Valve Surgery

Sponsor: Kuopio University Hospital

Updated 5 times since 2017 Last updated: Jan 20, 2009 Started: Mar 31, 2005 Primary completion: Dec 31, 2008 Completion: Dec 31, 2008

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00154115, this PHASE4 trial focuses on Heart Failure and remains completed. Sponsored by Kuopio University Hospital, it has been updated 5 times since 2005, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Mar 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Kuopio University Hospital

Data source: Kuopio University Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Kuopio, Finland